Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
DUZALLO
®
(lesinurad and allopurinol) tablets, for oral use
FASENRA
™
(benralizumab) Subcutaneous Injection 30 mg
IDHIFA®
(enasidenib)
Please
click
for full Prescribing Information, including Boxed Warning.
INGREZZA®
(valbenazine) tablets
RADICAVA®
(edaravone) IV infusion
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
ZURAMPIC®
(lesinurad) Tablets
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
Novavax Announces Closing of Public Offering
Monday, April 16, 2018 - 16:05